Editorial Contributor

Fred Colen is president of the CRM group at Boston Scientific.

He has worked for several medical device companies, including Guidant, where he launched the Delta T DDD Pacemaker platform, and St Jude Medical, where he served as managing director for the European subsidiary of the Cardiac Rhythm Management Division and as executive vice president, responsible for worldwide R&D for implantable pacemaker systems.